CEL-SCI to Raise $5.60 Million in Registered Direct Offering

Published: Jun 19, 2012

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, has entered into a definitive agreement to sell 16,000,000 shares of its common stock at a price per share of $0.35 pursuant to a registered direct offering to an institutional investor, representing gross proceeds of approximately $5.60 million.

Back to news